
KROS
Keros Therapeutics Inc.
$15.56
-$0.48(-2.99%)
41
Overall
--
Value
40
Tech
42
Quality
Market Cap
$641.72M
Volume
562.76K
52W Range
$9.12 - $72.37
Target Price
$23.33
Key Metrics Overview
Market Cap | $641.72M | P/E Ratio | 47.15 |
52W High | $72.37 | 52W Low | $9.12 |
Div Yield | N/A | Payout Ratio | 0.0% |
EPS Growth 3Y | -25.7% | 52W Position | 10.2% |
Overall Score | 41 | Value Score | -- |
Quality Score | 42 | Technical Score | 40 |
Growth Analysis
EPS Current Est | $0.33 | EPS Next Est | $-4.78 |
EPS Growth Est | -1548.5% | DPS Growth 3Y | N/A |
Revenue (5Y)
EBITDA (5Y)
A | B | C | D | |
---|---|---|---|---|
1 | Symbol | Price | Change | Vol |
2 | KROS | $15.56 | -3.0% | 562.76K |
3 | ||||
4 | ||||
5 | ||||
6 |